Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
1(9%)
Results Posted
86%(6 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_2
1
9%
Ph phase_3
1
9%
Ph not_applicable
6
55%
Ph phase_4
3
27%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
3(27.3%)
N/ANon-phased studies
6(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
Terminated2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (9.1%)
Phase 31 (9.1%)
Phase 43 (27.3%)
N/A6 (54.5%)

Trials by Status

completed764%
unknown19%
recruiting19%
terminated218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11